These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17293258)

  • 1. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management].
    Brice A; Hilbert U; Roger-Christoph S; Fernandez H; Dumenil AS; Descorps-Declère A; Mercier F; Benhamou D
    Ann Fr Anesth Reanim; 2004 Nov; 23(11):1084-8. PubMed ID: 15581725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
    Michalska-Krzanowska G
    Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
    Heilmann L; Wild C; Hojnacki B; Pollow K
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].
    Sobieszczyk S; Breborowicz GH; Markwitz W; Mallinger S; Adamski D; Kruszyński Z
    Ginekol Pol; 2002 Mar; 73(3):230-3. PubMed ID: 12092258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa for life-threatening post-partum haemorrhage.
    Ahonen J; Jokela R
    Br J Anaesth; 2005 May; 94(5):592-5. PubMed ID: 15708871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
    Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
    Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
    Bouwmeester FW; Jonkhoff AR; Verheijen RH; van Geijn HP
    Obstet Gynecol; 2003 Jun; 101(6):1174-6. PubMed ID: 12798521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
    Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
    Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan.
    Kobayashi T; Nakabayashi M; Yoshioka A; Maeda M; Ikenoue T
    Int J Hematol; 2012 Jan; 95(1):57-63. PubMed ID: 22160834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
    Holub Z; Feyereisl J; Kabelík L; Rittstein T
    Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.